Diagnosis and Management in Dementia

The Neuroscience of Dementia, Volume 1
Herausgeber: R Martin, Colin; Preedy, Victor R

• Gebundenes Buch

Produktbeschreibung

"Diagnosis and Management in Dementia: The Neuroscience of Dementia, Volume 1 consolidates different fields of dementia into a single book, covering a range of subjects, including Alzheimer's disease, Lewy body dementia, mixed dementia, vascular dementia, physical activity, risk factors, mortality, biomarkers, SPECT, CT, MRI, questionnaires, nutrition, sleep, delirium, hearing loss, agitation, aggression, delusions, anxiety, depression, hallucinations, psychosis, senile plaques, tau and amyloid-beta, neuroinflammation, molecular biology, and more. With an impact on millions globally, and billions of research dollars being invested in dementia research, this book will stimulate research in the area and inform researchers"--

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Elsevier Science
• Seitenzahl: 910
• Erscheinungstermin: 18. September 2020
• Englisch
• Gewicht: 2220g
• ISBN-13: 9780128158548
• ISBN-10: 0128158549
• Artikelnr.: 58815223

Inhaltsangabe

Section 1 Dementia: Introductory Chapters 1. A review of the different
types of dementia2. The classification of dementia: problems and
challenges3. Alzheimer's disease: an overview4. Dementia and competing
hypothesis - the example of Alzheimer's disease and its various
hypotheses5. Lewy body dementia - an overview6. Mixed dementia - an
overview7. Vascular dementia - an overview8. Linking in physical activity
and dementia9. Risk factors in dementia10. Mortality in dementia - linking
in delirium11. Rare forms of dementia12. Prion diseases and dementia13.
Dementia in Parkinson disease14. Dementia in traumatic brain injury15. Risk
factors in dementia - towards a coherent theory of dementia16. Genetics of
dementia
Section 2 Biomarkers, Psychometric Instruments, and Diagnosis 17.
Circulating biomarkers in neurodegenerative dementias - YKL-40 and
beyond18. Salivary biomarkers in Alzheimer's disease19. Use of
cerebrospinal fluid in diagnosis of dementias20. SPECT perfusion imaging in
assessment of neurodegenerative dementias21. Computerised tomography (CT)
in assessment of neurodegenerative dementias22. Magnetic resonance imaging
(MRI) in assessment of neurodegenerative dementias23. Questionnaires: The
mini-mental state examination (MMSE) and beyond24. The Cambridge Mental
Disorders of the Elderly Examination (CAMDEX) and applications to
dementia25. The Montreal Cognitive Assessment (MoCA) and applications to
dementia26. The Hopkins Verbal Learning Test (HVLT) and applications to
dementia27. The Addenbrooke's Cognitive Examination (ACE) and applications
to dementia28. ALBA Screening Instrument (ASI) and applications to
dementia29. The prediction of Alzheimer's disease
Section 3 Pharmacological Treatments for Dementia30. Cholinesterase
inhibitors in dementias - an overview31. NMDA receptor antagonists in
dementia - an overview32. Donepezil usage - a focused review33.
Rivastigmine usage - a focused review34. Galantamine usage - a focused
review35. Memantine - a focused review36. Failures and successes of
monoclonal antibodies - bapineuzumab and beyond37. Immunotherapies: an
overview
Section 4 Non-Pharmacological Treatments38. Internet counselling39.
Counselling in dementia40. Cognitive rehabilitation in dementia41.
Cognitive stimulation in dementia42. Anodal Transcranial Direct Current
Stimulation43. Nanoparticles: nanodiamond treatment in Alzheimer's
disease44. Increasing intakes and improving nutritional status in
dementia45. All-trans retinoic acid in Alzheimer's disease46. Environmental
enrichment in dementia47. Music therapy in dementia48. Aromatherapy in
dementia49. Massage in dementia50. Dancing in dementia51. Multisensory
Stimulation in Dementia52. Animal-assisted therapy in dementia53.
Occupational therapy in dementia